ライフサイエンスコーパス: lipemia

1 effects on postprandial vascular function or lipemia.

2 on of GLP-1 and GLP-2 decreased postprandial lipemia.

3 activity resulted in decreased postprandial lipemia.

4 ic acid (16:0) in the sn-2 position decrease lipemia.

5 of saturated fats may influence postprandial lipemia.

6 exposure, resulting in elevated postprandial lipemia.

7 s a primary role in determining postprandial lipemia.

8 en milk protein and milk fat on postprandial lipemia.

9 ent and an attenuated impact on postprandial lipemia.

10 ized SSOB resulted in 53% lower postprandial lipemia, 23% higher hepatic lipase activity, and a 25% l

11 esterol concentrations and less postprandial lipemia after the low-fat than the high-fat diet.

12 relationship between increased postprandial lipemia and atherosclerosis.

13 cturing dietary fat to modulate postprandial lipemia and lipid beta-oxidation in humans with differen

14 Through their effects on postprandial lipemia and oxidative stress, polyphenols may favorably

15 understanding the links between postprandial lipemia and the accumulation of lipid within vessels, a

16 t information on the control of postprandial lipemia and the biological effects of chylomicron remnan

17 ucoregulatory function, greater postprandial lipemia, and greater lipid oxidation rates than do their

18 ociations with glucoregulation, postprandial lipemia, and lipid oxidation rates.

19 ipoprotein particles; increased postprandial lipemia; and abnormal apolipoprotein A1 and B metabolism

20 dominal obesity and exaggerated postprandial lipemia are independent risk factors for cardiovascular

21 In children, postprandial lipemia, as indicated by the incremental area under the

22 d release (bioaccessibility) on postprandial lipemia by comparing lipid encapsulated by cell walls wi

23 erance (characterized by higher postprandial lipemia, cholesterol enrichment of triglyceride-rich lip

24 ts on postprandial fibrinolytic activity and lipemia, factor VII coagulant (FVII:c) activity, and act

25 se Western dietary habits cause postprandial lipemia for a major part of a day and, moreover, increas

26 Predictors of postprandial lipemia have not been explored in children.

27 with an oral fat load enhances postprandial lipemia in animals and humans.

28 ates the impact of dairy fat on postprandial lipemia in healthy subjects.

29 d in the sn-2 position decrease postprandial lipemia in healthy subjects.

30 impact of the cheese matrix on postprandial lipemia in humans has not yet been evaluated.In healthy

31 sma lipids and lipoproteins and postprandial lipemia in premenopausal African American and white wome

32 In humans, postprandial lipemia increased plasma glucagon concentrations and led

33 We concluded that postprandial lipemia induces pancreatic alpha cell dysfunction charac

34 experimental data suggest that postprandial lipemia is an independent risk factor for atherosclerosi

35 ffect of cell wall structure on postprandial lipemia is unknown.

36 d in glucomannan or glucomannan-spirulina on lipemia, liver glutathione status, antioxidant enzymes a

37 The greater HF morning lipemia occurred with elevated glucose, insulin, and non

38 of TM6SF2 in the regulation of postprandial lipemia, potentially through a similar function for TM6S

39 Exaggerated postprandial lipemia (PPL) is a factor in atherogenesis, involving en

40 A compared with DHA only during postprandial lipemia relative to control high-oleic acid meals; the s

41 in may explain the reduction in postprandial lipemia seen in clinical trials of this agent and may pr

42 not associated with fasting or postprandial lipemia test triacylglycerol or free fatty acids (P > or

43 ubgroup (n = 36) also underwent postprandial lipemia tests with lipid oxidation rate measurements.

44 ke had more dramatic effects on postprandial lipemia than did MSF after fat intake, possibly because

45 agents also improve fasting and postprandial lipemia, the latter more significantly than the former.

46 Vagal stimulation enhanced postprandial lipemia via effects on both chylomicron and VLDL metabol

47 oviral therapy predict enhanced postprandial lipemia, which is an emerging cardiovascular disease ris

48 , we tested the hypothesis that postprandial lipemia with its characteristic elevation of triglycerid